2,196
Views
14
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Formulation, characterization, and evaluation of ligand-conjugated biodegradable quercetin nanoparticles for active targeting

, , &
Pages 960-970 | Received 12 Oct 2014, Accepted 06 Jan 2015, Published online: 27 Mar 2015
 

Abstract

The aim of this study was to design a targeted drug delivery system carrying a natural anticancer drug Quercetin (Qu), specifically for skin cancer. A central composite design was applied separately for each ligand, and the quadratic model was used for the process. The surface morphology was confirmed by transmission electron microscopy (TEM) and Fourier transform infrared spectroscopy (FTIR), and in vitro release studies were also performed. The MTT assay was performed against two different cell lines, to measure their anticancer potentials and their targeting ability. The study thus reveals that MA-Qu-PLGA and FA-Qu-PLGA nanoparticles (NPs) can be used as effective drug delivery systems for skin cancer treatment encompassing natural drugs.

Acknowledgements

The authors acknowledge the University Grant Commission-SAP [F. No.3-54/2011(SAP-II)], New Delhi, India, and the University Grant Commission (UGC), New Delhi, Under MRP Scheme Major Research project, F. No 39-170/2010 (SR), for financial assistance. One of the authors extend their gratitude towards the head of the Cosmetic Lab, University Institute of Pharmacy, Pt., Ravishankar Shukla University, Raipur (C.G.), for providing facilities to carry out research work.

Declaration of interest

The authors report no declarations of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.